-
Psilocybin Compassionate Use in Germany: Lea Mertens and Andrea Jungaberle on the First Patients, Payers and Practicalities
Last summer, Germany’s medicines regulator quietly green-lit a psilocybincompassionate use program, the first such pathway in the European Union(see Germany Establishes EU’s First Psilocybin Compassionate AccessProgram). Two centres are permitted to offer psilocybin dosing at present:OVID Clinic Berlin, a private clinic in the nation’s capital, and the CentralInstitute of Mental Health (CIMH) in Mannheim, a…
-
Psilocybin therapy available in Germany for the first time – Compassionate Use Program
Psilocybin therapy is now available in Germany for the first time outside of scientific studies. The OVID Clinic Berlin is a specialized treatment center for people with treatment-resistant depression and is now part of an officially approved compassionate use program for psilocybin therapy. The compassionate use program is not a substitute for psilocybin approval. We…
-
Relevant studies on the use of ketamine in the treatment of depression
Ketamine has been used safely and with few complications in medicine for almost 60 years. Its potential as an antidepressant was a chance discovery and has been the subject of international research for about 25 years: In low doses, ketamine has a strong antidepressant and antisuicidal effect that occurs within a few hours or days…
